Treating Anal HSIL Cuts Anal Cancer Risk in Persons With HIV

THURSDAY, June 16, 2022 -- Among persons living with HIV who have anal high-grade squamous intraepithelial lesions (HSILs), those who receive treatment have a lower rate of progression to anal cancer than those who receive active monitoring without...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news